|4Jan 28, 4:10 PM ET

DALE STEPHEN 4

4 · Kura Oncology, Inc. · Filed Jan 28, 2022

Insider Transaction Report

Form 4
Period: 2022-01-26
DALE STEPHEN
Chief Medical Officer
Transactions
  • Award

    Option to purchase common stock

    2022-01-26+261,000261,000 total
    Exercise: $14.15Exp: 2032-01-25Common Stock (261,000 underlying)
  • Award

    Common Stock

    2022-01-26+36,90036,900 total
Footnotes (2)
  • [F1]Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26.
  • [F2]This option vests in 48 equal monthly installments commencing on the grant date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT